Effects of FK506 on an experimental model of colitis in rats
- 1 June 1995
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 9 (3), 301-307
- https://doi.org/10.1111/j.1365-2036.1995.tb00385.x
Abstract
Aim: To assess the effects of FK506, a newly developed immunosuppressant, on experimental colitis in rats. Methods: Experimental colitis was induced by a single colonic instillation of hapten 2,4,6-trinitrobenzene sulphonic acid (TNB) in anaesthetized rats. Rats received 30 mg TNB dissolved in 0.25 mL of 50% ethanol, and were sacrificed on day 5 following 4 days dosing with FK506 (0.25, 0.5, 1.0, 2.0 mg/kg, s.c.) or vehicle. Mucosal prostanoid concentrations were determined using high performance liquid chromotography. Tissue myeloperoxidase activities were measured. The effects of FK506 on superoxide radical formation by neutrophils in both rats and humans were also estimated in vitro. Results: Administration of FK506 significantly reduced the colonic damage in a dose-dependent manner. Activities of myeloperoxidase and concentrations of 6-keto-prostaglandin Fl1α (6-keto-PGF1α, PGF2α and PGE2 in colonic tissue increased significantly following induction of experimental colitis, however, FK506 did not affect these changes. FK506 reduced stimulant-induced superoxide radical formation by neutrophils in rats and humans. Conclusion: FK506 decreased superoxide radical generation by neutrophils, which might contribute to the lessening of colonic damage in this model.Keywords
This publication has 32 references indexed in Scilit:
- Effects of FK506, an immunosuppressive agent, on genesis of water-immersion stress-induced gastric lesions in ratsDigestive Diseases and Sciences, 1994
- Renal allograft rejection: expression and function of VCAM-1 on tubular epithelial cellsClinical and Experimental Immunology, 1993
- Protective Effect of FK506 on Ischemia/Reperfusion-Induced Myocardial Damage in Canine HeartJournal of Cardiovascular Pharmacology, 1993
- MECHANISM AND PREVENTION OF CHRONIC COLONIC INFLAMMATION WITH TRINITROBENZENE SULFONIC ACID IN RATSClinical and Experimental Pharmacology and Physiology, 1992
- FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in ratsHepatology, 1991
- Role of reactive oxygen metabolites in experimental colitis.Gut, 1990
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- A chemiluminescent probe with a Cypridina luciferin analog, 2‐methyl‐6‐phenyl‐3,7‐dihydroimidazo[1,2‐a]pyrazin‐3‐one, specific and sensitive for O2− production in phagocytizing macrophagesFEBS Letters, 1986
- Prostanoids cytoprotection for maintaining remission in ulcerative colitis failure of 15(R), 15-methylprostaglandin E2Digestive Diseases and Sciences, 1983